100 related articles for article (PubMed ID: 8579069)
1. Chronobiological circadian aspects of serum lactate dehydrogenase and serum thymidine kinase in monitoring multiple myeloma.
Pasqualetti P; Casale R; Collacciani A
Am J Hematol; 1996 Feb; 51(2):176-7. PubMed ID: 8579069
[No Abstract] [Full Text] [Related]
2. [Serum thymidine kinase in the monitoring of lymphoma patients].
Rauhala A; Rantalaiho V; Almqvist A; Putkonen M
Duodecim; 1995; 111(5):428-34. PubMed ID: 8674444
[No Abstract] [Full Text] [Related]
3. Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma.
Simonsson B; Brenning G; Källander C; Ahre A
Eur J Clin Invest; 1987 Aug; 17(4):336-9. PubMed ID: 3117570
[TBL] [Abstract][Full Text] [Related]
4. [Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease].
Scudla V; Bacovský J; Papajík T; Budíková M; Srovnalík K
Vnitr Lek; 1994 Mar; 40(3):151-6. PubMed ID: 8184566
[TBL] [Abstract][Full Text] [Related]
5. [Serum LDH and myeloma. Correlation with the degree of bone marrow infiltration].
Ogea García JL; Blanco Molina MA; Andrés P; Muñoz R; Jiménez Alonso J; Pérez Jiménez F
Rev Esp Oncol; 1985; 32(2):207-13. PubMed ID: 3843455
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of some biochemical and immunologic factors in the management of multiple myeloma].
Abdulkadyrov KM; Stel'mashenko LV; Bessmel'tsev SS; Lubo-Lesnichenko IF; Sel'tser AV; Rozanova OE; Gubarenko NK; Bubnova LN; Mnuskina MM; Zhuchikhina AA; Blinov MN; Gritskevich NL
Vopr Onkol; 1998; 44(3):304-9. PubMed ID: 9695777
[TBL] [Abstract][Full Text] [Related]
7. [Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage].
Scudla V; Papajík T; Bacovský J; Budíková M; Klímová D
Vnitr Lek; 1994 Mar; 40(3):157-62. PubMed ID: 8184567
[TBL] [Abstract][Full Text] [Related]
8. [Drug-resistant multiple myeloma with high serum levels of lactate dehydrogenase and neutrophil infiltration in pleural effusion].
Kozawa M; Hata H; Kawaguchi T; Tsuji N; Mori S; Harada N; Nakahashi E; Sakata K; Matsuzaki H; Takatsuki K
Rinsho Ketsueki; 1994 Jan; 35(1):49-53. PubMed ID: 8139102
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of telomerase activity in multiple myeloma.
Shiratsuchi M; Muta K; Abe Y; Motomura S; Taguchi F; Takatsuki H; Uike N; Umemura T; Nawata H; Nishimura J
Cancer; 2002 Apr; 94(8):2232-8. PubMed ID: 12001122
[TBL] [Abstract][Full Text] [Related]
10. The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase.
Cesana C; Giachetti R; Almici C; Garau D; Mangoni L; Pesci A; Carlo-Stella C
Haematologica; 1998 Mar; 83(3):276-9. PubMed ID: 9573681
[No Abstract] [Full Text] [Related]
11. Kinetics of serum TK and LDH during therapy for AML.
Catalano L; Frigeri F; Camera A; De Rosa G; Festinese R; Rotoli B
Haematologica; 1990; 75(3):301-3. PubMed ID: 2227633
[No Abstract] [Full Text] [Related]
12. Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.
Micke O; Schäfer U; Wörmann B; Hiddemann W; Willich N
Anticancer Res; 1997; 17(4B):3007-10. PubMed ID: 9329587
[TBL] [Abstract][Full Text] [Related]
13. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.
Bouafia F; Drai J; Bienvenu J; Thieblemont C; Espinouse D; Salles G; Coiffier B
Bull Cancer; 2004; 91(7-8):E229-40. PubMed ID: 15381461
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of elevated lactate dehydrogenase and creatine kinase in patients with rhabdomyosarcoma.
Moritake H; Kamimura S; Akiyoshi K; Nagatoshi Y; Chuman H; Okamura J
Med Pediatr Oncol; 2003 Mar; 40(3):187-8. PubMed ID: 12518348
[No Abstract] [Full Text] [Related]
15. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
16. Prosthetic valvular hemolysis: a potential pitfall in the routine use of serum lactate dehydrogenase as tumor marker in patients with germ cell testicular tumors.
Leibovitch I; Veinreb M; Sterenberg I; Alkalay R
Isr Med Assoc J; 2006 Sep; 8(9):659-60. PubMed ID: 17058425
[No Abstract] [Full Text] [Related]
17. Lactate dehydrogenase production and release in a newly established human myeloma cell line.
Hatakeyama N; Daibata M; Nemoto Y; Ohtsuki Y; Taguchi H
Am J Hematol; 2001 Apr; 66(4):267-73. PubMed ID: 11279638
[TBL] [Abstract][Full Text] [Related]
18. Changes of serum thymidine kinase in children with acute leukemia.
Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.
Deichmann M; Benner A; Waldmann V; Bock M; Jäckel A; Näher H
J Exp Clin Cancer Res; 2000 Sep; 19(3):301-7. PubMed ID: 11144523
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
